Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.680
-0.120 (-6.67%)
Feb 21, 2025, 4:00 PM EST - Market closed
Celularity Employees
Celularity had 120 employees as of December 31, 2023. The number of employees decreased by 105 or -46.67% compared to the previous year.
Employees
120
Change (1Y)
-105
Growth (1Y)
-46.67%
Revenue / Employee
$401,667
Profits / Employee
-$292,100
Market Cap
37.77M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 120 | -105 | -46.67% |
Dec 31, 2022 | 225 | 0 | - |
Dec 31, 2021 | 225 | 63 | 38.89% |
Dec 31, 2020 | 162 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CELU News
- 2 months ago - Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - GlobeNewsWire
- 2 months ago - Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 - GlobeNewsWire
- 3 months ago - Celularity Inc. Announces Receipt of Nasdaq Notification - GlobeNewsWire
- 3 months ago - Celularity's Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific - GlobeNewsWire
- 4 months ago - Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel - GlobeNewsWire
- 4 months ago - Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal - GlobeNewsWire
- 4 months ago - Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc. - GlobeNewsWire
- 6 months ago - Celularity to Present at H.C. Wainwright's 26th Annual Global Investment Conference - GlobeNewsWire